Premium Company Profile Pain Therapeutics

Summary

Introduction

Pain Therapeutics was initially focused on building a franchise of pain management products through partnering with the scientific and medical community. In 2006, Pain Therapeutics changed its focus from being a clinical research based company to becoming a fully integrated biopharmaceutical franchise through in-licensing activities.

Scope

• Contains corporate strategy, value chain presence and SWOT Analysis
• Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
• Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Pain Therapeutics is focused on the development and commercialization of pharmaceutical products for pain management and hematology/oncology indications. The company has three investigational drug candidates in clinical programs, namely, Remoxy and PTI-202 which are in the Phase III and Phase I stage respectively.

Pain Therapeutics derives its revenues mainly from program fee and collaboration related to the strategic alliance with King Pharmaceuticals for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers.

The company's total revenues increased significantly during the fiscal year 2006, from $5 million in 2005 to $54 million in 2006 The company's major contributor to the revenues during 2006 was program fee related to the strategic alliance with King Pharmaceuticals, which recorded revenues of $26 million during 2006.

Reasons to Purchase

• Access all the important information and analysis on the company in a single report
• Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Contents

• Overview
• Catalyst
  • Summary
  • Company Structure
  • Company Overview And Key Facts
  • Business Description
  • Landmark Products And Services
  • History
  • Company Financials
  • Stock Market Performance
  • P&L
  • Balance Sheet
  • Cash Flow
  • Business Segment Performance
  • Products & Services
  • Pipeline Products
  • Ac Forecast Product Sales
  • Competitors And Strategic Business Relationships
  • Key Competitors
  • Key Suppliers
  • Shareholding Structure
  • Strategy
  • Company View
  • Corporate Strategy
  • Swot Analysis
• Overview
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
  • Value Chain Analysis
• Overview
  • Discovery And Product Development
  • Scorecard
• Overview
  • Scorecard Analysis
  • Key Employees
  • List Of Key Employees
  • Key Employee Biographies
  • Financial And Operational Overview
  • Financial And Operational Overview
• Appendix
  • Ask The Analyst
  • Datamonitor Consulting
  • Disclaimer
  • Figure 1: Pain Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
  • Figure 2: Pain Therapeutics - Key Strategic Revenues, 2006-2010 ($ Mn)
  • Table 1: Pain Therapeutics - Key Facts
  • Table 2: Pain Therapeutics - Year-End Share Price And Market Capitalization, 2002-2006 ($)
  • Table 3: Pain Therapeutics - Key Events Impacting Share Price Performance
  • Table 4: Pain Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
  • Table 5: Pain Therapeutics - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
  • Table 6: Pain Therapeutics - Balance Sheet, 2002-2006 ($ Mn)
  • Table 7: Pain Therapeutics - Cash Flow, 2002-2006 ($ Mn)
  • Table 8: Pain Therapeutics - Revenue Breakdown, 2002-2006 ($ Mn)
  • Table 9: Pain Therapeutics - In-House Pipeline Products
  • Table 10: Pain Therapeutics - Collaboration Pipeline Products
  • Table 11: Pain Therapeutics - Forecast Sales, 2006-2010 ($ Mn)
  • Table 12: Pain Therapeutics - Key Competitors
  • Table 13: Pain Therapeutics - Key Suppliers
  • Table 14: Pain Therapeutics - Key Shareholders
  • Table 15: Pain Therapeutics - Swot Analysis Summary
  • Table 16: Pain Therapeutics - Value Chain Analysis
  • Table 17: Pain Therapeutics - Scorecard
  • Table 18: Pain Therapeutics - Key Employees
  • Table 19: Pain Therapeutics - Financial And Operational Overview